5.25
+0.01
+(0.19%)
At close: January 30 at 4:00:01 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-43,831.00
-39,350.00
-45,456.00
6,806.00
-10,776.00
Investing Cash Flow
-66,943.00
16,430.00
-16,542.00
8,676.00
9,618.00
Financing Cash Flow
122,299.00
25,155.00
43,049.00
30,711.00
15,428.00
End Cash Position
70,337.00
54,031.00
54,816.00
73,537.00
27,449.00
Capital Expenditure
-117.00
-45.00
-440.00
-1,334.00
-514.00
Issuance of Capital Stock
128,679.00
25,329.00
43,239.00
30,922.00
15,830.00
Repayment of Debt
-189.00
-174.00
-190.00
-211.00
-402.00
Free Cash Flow
-43,948.00
-39,395.00
-45,896.00
5,472.00
-11,290.00
12/31/2020 - 9/8/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ANRO Alto Neuroscience, Inc.
4.4600
+5.44%
ABVX ABIVAX Société Anonyme
5.90
+0.51%
OKUR OnKure Therapeutics, Inc.
5.83
+10.42%
STOK Stoke Therapeutics, Inc.
10.99
+4.57%
BCYC Bicycle Therapeutics plc
12.77
-1.62%
EWTX Edgewise Therapeutics, Inc.
28.00
-1.48%
NAMS NewAmsterdam Pharma Company N.V.
21.77
+4.76%
KURA Kura Oncology, Inc.
8.03
+4.42%
SLRN Acelyrin, Inc.
1.9800
+3.66%
ENGN enGene Holdings Inc.
7.10
-3.92%